Cargando…
Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147395/ https://www.ncbi.nlm.nih.gov/pubmed/32281766 http://dx.doi.org/10.1097/TA.0000000000002694 |
| _version_ | 1783520411975155712 |
|---|---|
| author | Moore, Hunter B. Barrett, Christopher D. Moore, Ernest E. McIntyre, Robert C. Moore, Peter K. Talmor, Daniel S. Moore, Frederick A. Yaffe, Michael B. |
| author_facet | Moore, Hunter B. Barrett, Christopher D. Moore, Ernest E. McIntyre, Robert C. Moore, Peter K. Talmor, Daniel S. Moore, Frederick A. Yaffe, Michael B. |
| author_sort | Moore, Hunter B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7147395 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71473952020-04-15 Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? Moore, Hunter B. Barrett, Christopher D. Moore, Ernest E. McIntyre, Robert C. Moore, Peter K. Talmor, Daniel S. Moore, Frederick A. Yaffe, Michael B. J Trauma Acute Care Surg Special Report Lippincott Williams & Wilkins 2020-06 2020-03-25 /pmc/articles/PMC7147395/ /pubmed/32281766 http://dx.doi.org/10.1097/TA.0000000000002694 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Surgery of Trauma. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| spellingShingle | Special Report Moore, Hunter B. Barrett, Christopher D. Moore, Ernest E. McIntyre, Robert C. Moore, Peter K. Talmor, Daniel S. Moore, Frederick A. Yaffe, Michael B. Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? |
| title | Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? |
| title_full | Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? |
| title_fullStr | Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? |
| title_full_unstemmed | Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? |
| title_short | Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? |
| title_sort | is there a role for tissue plasminogen activator as a novel treatment for refractory covid-19 associated acute respiratory distress syndrome? |
| topic | Special Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147395/ https://www.ncbi.nlm.nih.gov/pubmed/32281766 http://dx.doi.org/10.1097/TA.0000000000002694 |
| work_keys_str_mv | AT moorehunterb istherearolefortissueplasminogenactivatorasanoveltreatmentforrefractorycovid19associatedacuterespiratorydistresssyndrome AT barrettchristopherd istherearolefortissueplasminogenactivatorasanoveltreatmentforrefractorycovid19associatedacuterespiratorydistresssyndrome AT mooreerneste istherearolefortissueplasminogenactivatorasanoveltreatmentforrefractorycovid19associatedacuterespiratorydistresssyndrome AT mcintyrerobertc istherearolefortissueplasminogenactivatorasanoveltreatmentforrefractorycovid19associatedacuterespiratorydistresssyndrome AT moorepeterk istherearolefortissueplasminogenactivatorasanoveltreatmentforrefractorycovid19associatedacuterespiratorydistresssyndrome AT talmordaniels istherearolefortissueplasminogenactivatorasanoveltreatmentforrefractorycovid19associatedacuterespiratorydistresssyndrome AT moorefredericka istherearolefortissueplasminogenactivatorasanoveltreatmentforrefractorycovid19associatedacuterespiratorydistresssyndrome AT yaffemichaelb istherearolefortissueplasminogenactivatorasanoveltreatmentforrefractorycovid19associatedacuterespiratorydistresssyndrome |